• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOTRONIK AG, BUELACH, SWITZERLAND PULSAR-18 5/170/135; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOTRONIK AG, BUELACH, SWITZERLAND PULSAR-18 5/170/135; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Model Number 366836
Device Problem Difficult to Remove (1528)
Patient Problem Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 08/11/2020
Event Type  Injury  
Event Description
A pulsar-18 peripheral stent system was selected for treatment of a severely calcified lesion (95 percent stenosis degree) in a mildly tortuous mid left superficial femoral artery.After stent release during attempt to remove the system, the guide wire and stent system were twined together and could not be withdrawn.Eventually it was necessary to perform an incision to take out the guidewire, stent and stent system.
 
Manufacturer Narrative
The returned device was subjected to a detailed technical analysis and the corresponding production documentation was reviewed to establish whether a deviation from the manufacturing process could be the cause for this event.Further, the angiographic material was reviewed.The technical investigation of the returned delivery system revealed that the outer shaft has been retracted by about 765 mm.The outer shaft was inspected for stent imprints.The length of the imprints was measured and implies that the stent had the correct length prior to release.The provided angiographic material show the implanted complaint stent.Geometric distortions of the stent structure are visible as well as the attempt to withdraw the complaint instrument.The inhomogeneous radiopacity along the stent length is indicative of stent compression.The actual complaint event is not visible.Review of the production documentation confirmed that the instrument was manufactured according to specifications and passed all in-process and final inspections.A 100 percent stent length control is conducted during the manufacturing process.Based on the conducted investigations no manufacturing related root cause could be determined.It seems likely that the reported event is related to the handling of the device.Any slack in the delivery system outside the patient could result in incorrect stent placement, potential stent compression or elongation as stated in the instruction for use.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PULSAR-18 5/170/135
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
BIOTRONIK AG, BUELACH, SWITZERLAND
ackerstrasse 6
buelach CH-81 80
CH  CH-8180
MDR Report Key10511718
MDR Text Key206290347
Report Number1028232-2020-03838
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
PMA/PMN Number
P160025
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 09/04/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/09/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/31/2021
Device Model Number366836
Device Catalogue NumberSEE MODEL NO.
Device Lot Number12184271
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/26/2020
Date Manufacturer Received03/26/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-